Patient Blood Management Market Worth $15.3 Billion by 2024 - Exclusive Report by MarketsandMarkets™
On the basis of end users, the market is segmented into hospitals and blood banks.
CHICAGO, Dec. 13, 2019 /PRNewswire/ -- According to the new market research report "Patient Blood Management Market by Product (Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device), Accessories (Syringes, Vials), Reagents, Software)), Component, End User (Blood Bank, Hospital) - Global Forecast to 2024", published by MarketsandMarkets™, the Patient Blood Management Market is projected to reach USD 15.3 billion by 2024 from USD 10.7 billion in 2019, at a CAGR of 7.4% from 2019 to 2024.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131352979
Globally, the demand for donated blood is increasing because of greater volume of sophisticated medical surgical procedures conducted and the increasing number of trauma cases due to road accidents. These procedures require blood transfusions to make up for blood loss incurred during the procedures. Thus, the rising number of accidents, trauma cases, and surgical procedures performed are contributing to the market growth, thereby increasing the need for patient blood management products.
The blood transfusion segment of instruments to register significant growth over the forecast period
Based on product, the Patient Blood Management Market is segmented into instruments, accessories, reagents & kits, and software. The instrument segment is further sub-segmented into blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, and blood storage devices. Among these, the blood transfusion segment is anticipated to register significant growth over the forecast period. Growth in this segment is attributed to the upsurge in demand for blood components across the globe and the increase in government initiatives towards blood donation. In addition, newly approved indications for apheresis treatment such as acute disseminated encephalomyelitis, autoimmune hemolytic anemia, and cardiac neonatal lupus will further supplement the growth of this segment
Browse in-depth TOC on "Patient Blood Management Market"
60 – Tables
34 – Figures
152 – Pages
The whole blood segment is projected to hold the largest share of the market, by component, during the forecast period of 2019 to 2024
By component, the market is segmented into whole blood and blood components. The whole blood segment is expected to hold a major share of the market during the forecast period. An increase in the number of surgical procedures coupled with rising incidences of blood-related disorders that require blood transfusion during treatment are the key factors supporting the market growth of this segment.
Blood banks were the key end users in the Patient Blood Management Market in 2019
On the basis of end users, the market is segmented into hospitals and blood banks. The increasing number of blood donations has increased the need for proper management of blood. Blood banks are the key end users for various blood processing devices, blood collection devices, and blood storage devices. The key factors attributing to the growth of the blood banks segment include the growing awareness about blood donations, rising automation in blood banks, and the increase in the number of blood banks in developing countries.
Get 10% Customization on this Research Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=131352979
The Asia Pacific region is expected to register significant growth during the forecast period of 2019-2024
The Patient Blood Management Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Asia Pacific blood management market is expected to register significant growth over the forecast period due to the modernization of healthcare infrastructure, increasing prevalence of chronic lifestyle diseases, and rising awareness about blood donation & blood safety. China accounted for a major share of the Asia Pacific market, owing to a large patient pool and favorable government guidelines to improve healthcare infrastructure in the country.
The major players in the Patient Blood Management Market include Haemonetics Corporation (US), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (US), B. Braun Melsungen AG (Ireland), Macopharma (US), bioMérieux SA (France), Asahi Kasei Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Grifols, S.A. (Spain), F. Hoffmann-La Roche LTD (Switzerland), LivaNova PLC (UK), Danaher Corporation (US), Mediware Information Systems (US), Kawasumi Laboratories, Inc. (Japan), Haier Biomedical (China), Diatron (Hungary), and BAG Diagnostics GmbH (Germany), among others.
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Get Special Pricing on Bundle Reports:
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=131352979
Browse Related Reports:
Blood Collection Market by Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation, Glucose, Needle, Lancet, ESR, Syringe, Blood Bag), Method (Manual, Automated), End User (Hospital, Blood Bank Center, Academics, Home Care) - Global Forecast to 2022
Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) - Global Forecast to 2021
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/patient-blood-management-market.asp
Visit Our Website: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/patient-blood-management.asp
View original content:http://www.prnewswire.com/news-releases/patient-blood-management-market-worth-15-3-billion-by-2024--exclusive-report-by-marketsandmarkets-300974548.html
SOURCE MarketsandMarkets
